Mather Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-48
| Closed | -$3.89K | – | 1742 |
|
|
2025
Q1 | $3.89K | Hold |
48
| – | – | ﹤0.01% | 1448 |
|
|
2024
Q4 | $4.32K | Hold |
48
| – | – | ﹤0.01% | 1402 |
|
|
2024
Q3 | $4.74K | Sell |
48
-827
| -95% | -$81.7K | ﹤0.01% | 1308 |
|
|
2024
Q2 | $83K | Buy |
875
+827
| +1,723% | +$78.5K | ﹤0.01% | 859 |
|
|
2024
Q1 | $4.29K | Buy |
+48
| New | +$4.29K | ﹤0.01% | 1378 |
|
|
2014
Q2 | – | Sell |
-193,710
| Closed | -$9.2M | – | 25 |
|
|
2014
Q1 | $9.2M | Sell |
193,710
-38,562
| -17% | -$1.83M | 3.37% | 13 |
|
|
2013
Q4 | $10.1M | Buy |
232,272
+3,801
| +2% | +$165K | 3.84% | 11 |
|
|
2013
Q3 | $9.84M | Sell |
228,471
-2,940
| -1% | -$127K | 4.08% | 10 |
|
|
2013
Q2 | $8.04M | Buy |
+231,411
| New | +$8.04M | 3.47% | 12 |
|